I am a
Home I AM A Search Login

Papers of the Week


2022 May 14


Emerg Med Australas

Patients treated for acute headache with intranasal droperidol spend less time in the emergency department: A retrospective observational study.

Authors

Stern A, Munro A, King C, Knight A, Bruce E, Stacey J, Hammond S, Holland A
Emerg Med Australas. 2022 May 14.
PMID: 35568501.

Abstract

Headache is a common presenting complaint to the ED. Using time from the first provider to discharge as a surrogate for effectiveness, we aimed to determine if intranasal (IN) droperidol is as beneficial as usual treatment for acute headache in the ED.